NWF Advisory Services’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,500
Closed -$125 330
2024
Q1
$125 Buy
+2,500
New +$2.43K ﹤0.01% 336
2023
Q4
Sell
-3,000
Closed -$300 306
2023
Q3
$300 Sell
3,000
-2,000
-40% -$5.74K ﹤0.01% 292
2023
Q2
$3.25K Hold
5,000
﹤0.01% 282
2023
Q1
$3.25K Buy
+5,000
New +$15K ﹤0.01% 281

Other funds holding CTSO

NWF Advisory Services's CTSO Position: Q1 2026 in Review

NWF Advisory Services held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 104,139 shares worth $59K. The position accounts for 0.01% of the portfolio, ranked #400.

NWF Advisory Services first reported a position in CTSO in Q1 2023 and has held it in 12 quarters since. The position peaked at $160K in Q2 2023. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • NWF Advisory Services held 104,139 shares of Cytosorbents Corp worth $59K as of Q1 2026.
  • NWF Advisory Services left its Cytosorbents Corp share count unchanged in Q1 2026.
  • Cytosorbents Corp made up 0.01% of NWF Advisory Services's portfolio in Q1 2026, its #400 holding.
  • NWF Advisory Services first reported a position in Cytosorbents Corp in Q1 2023 and has held it in 12 quarters since.
  • NWF Advisory Services's Cytosorbents Corp position peaked at $160K in Q2 2023.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on NWF Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.